form (29 -35) . Furthermore, the inflammasome component apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) is required for the generation of active IL-1␤ in S. aureus-stimulated bone marrow (BM)-derived macrophages in vitro (36) . In the present study, we investigated the requirement and differential contribution of IL-1␣, IL-1␤, and ASC to IL-1Rmediated neutrophil recruitment and host defense against a cutaneous S. aureus challenge in vivo.
Materials and Methods

S. aureus strains
All strains used were derived from S. aureus strain RN6390, which has a known 11-bp deletion in the rsbU gene within the sigB operon (37) . Strain SH1000 is a derivative of RN6390 with the rsbU gene restored (38) . All data presented were obtained using the S. aureus bioluminescent strain ALC2906, which is strain SH1000 containing the shuttle plasmid pSK236 with the penicillin-binding protein 2 ( pbp2) promoter fused to the luxABCDE reporter cassette from Photorhabdus luminescens as previously described (15) . In control experiments, strain ALC2506, a nonbioluminescent control SH1000 strain containing pSK236 with a promoterless luxABCDE reporter cassette, was used (data not shown).
Preparation of S. aureus for skin inoculation
The S. aureus bioluminescent strain ALC2906 and nonbioluminescent strain ALC2506 have a chloramphenicol resistance plasmid selection marker and all cultures were performed in the presence of chloramphenicol (10 g/ml; Sigma-Aldrich). S. aureus was streaked onto tryptic soy agar (tryptic soy broth (TSB) plus 1.5% bacto agar plus chloramphenicol; BD Biosciences/Sigma-Aldrich) and grown overnight at 37°C in a bacterial incubator. Colonies of S. aureus were grown overnight at 37°C in a shaking incubator (240 rpm) in TSB plus chloramphenicol. Mid-logarithmic phase bacteria were obtained after a 3-h subculture of a 1/50 dilution of the overnight culture. Bacterial cells were pelleted, resuspended, and washed three times in PBS. Bacterial concentrations were estimated by measuring the absorbance at 600 nm (A 600 ; DU 640B spectrophotometer; Beckman Coulter). CFUs were verified by plating dilutions of the inoculum onto TSB agar Ϯ chloramphenicol overnight.
Mice
All mice have a C57BL/6J genetic background. IL-1␣-(F 4 ), IL-1␤-(F 8 ), and IL-1␣/IL-1␤-(F 11 ) deficient mice were generated as previously described (39) . ASC-deficient mice were generated as previously described (40) . Mice deficient in IL-1RI (IL1r tm1Imx ) (F 8 ) and wt control mice were obtained from The Jackson Laboratory. All of these mouse colonies at University of California (Los Angeles, CA (UCLA)) are pathogen free and are maintained in autoclaved cages.
Mouse model of cutaneous S. aureus infection
All procedures were approved by the UCLA Animal Research Committee. The mice were shaved on the back and inoculated s.c. with 100 l of mid-logarithmic growth phase S. aureus strain ALC2906 (ϳ2 ϫ 10 6 CFUs/ 100 l ϭ 1/10 dilution of A 600 of 0.5/ml) in sterile pharmacy grade saline (0.9%) using a 27-gauge tuberculin syringe (Abbott Laboratories). Groups of four to five mice were used in each experiment followed by one to two repeats to confirm results. Measurements of total lesion size (cm 2 ) were made by analyzing digital photographs (Nikon Coolpix 5400) of mice taken every 1-3 days using the software program "Image J" (National Institutes of Health Research Services Branch (http://rsbweb.nih.gov/ij/)) and a millimeter ruler as a reference.
Quantification of in vivo S. aureus (in vivo bioluminescence)
In vivo bioluminescence was performed using the Xenogen IVIS imaging system at the Crump Institute for Molecular Imaging (UCLA) as previously described (15) . Mice were anesthetized via an i.p. injection of a mix of ketamine and xylazine (100 and 20 mg/kg body weight, respectively). Data are presented on color scale overlaid on a grayscale photograph of mice and quantified as total flux (photons per second) within a circular region of interest (1 ϫ 10 3 pixels) using Living Image software (Xenogen) (lower limit of detection: 1 ϫ 10 4 photons/s).
Tissue embedding and staining
For histological analysis, lesional 8-mm punch biopsy (Acuderm) specimens were bisected and one half was fixed in formalin (10%) and embed-ded in paraffin and the other half was embedded in Tissue-Tek OTC compound (Sakura Finetek) and frozen in liquid nitrogen. H&E and Gram stains were performed on paraffin sections (4 m) by the Tissue Procurement and Histology Core Laboratory and Histopathology Laboratory (UCLA), according to guidelines for clinical samples.
Immunoperoxidase labeling
Detection of Gr-1 (Ly-6G)-positive cells, Mac-3-positive cells, or IL-1␤ expression on frozen cryostat specimens of lesional skin punch biopsy specimens were performed with the following biotinylated mAbs: rat anti-Gr-1 mAb (clone RB6-8C5; IgG2b isotype; 1-5 g/ml; BD Pharmingen), rat anti-Mac-3 mAb (clone CI:A3-1, IgG1 isotype; 1 g/ml; Biolegend), or mouse anti-mouse IL-1␤ mAb (20 g/ml; clone 1400.24.17; Pierce-Endogen) and corresponding biotinylated isotype control mAbs using the immunoperoxidase method as previously described (15, 41) .
Myeloperoxidase (MPO) assay
MPO activity from lesional skin was obtained from tissue homogenates (Tissue-tearer; Biospec Products) of 8-mm punch biopsy specimens (Acuderm) using a MPO assay kit according to the manufacturer's recommendations (Cytostore).
ELISAs
Protein levels of IL-1␣, IL-1␤, KC, and MIP2 (picograms per milligram of tissue) from lesional skin were obtained from tissue homogenates (Tissuetearer; Biospec Products) of 8-mm punch biopsy specimens performed at various time points after S. aureus skin inoculation in 0.01% Triton using commercially available ELISA kits (KC and MIP2 obtained from R&D systems; IL-1␣ and IL-1␤ obtained from BD Pharmingen).
BM reconstitution
BM reconstitution experiments were performed as previously described (15, 42) . BM was flushed from tibias and femurs from donor mice, RBCdepleted using ACK/RBC lysis buffer (0.15 M ammonium chloride (NH 4 Cl), 1 mM potassium bicarbonate (KHCO 3 ), 0.1 mM EDTA (pH 7.3)), and washed twice in PBS. A total of 1 ϫ 10 7 BM cells were injected into the tail veins of lethally irradiated (1000 rad) recipient mice. Reconstituted mice were maintained in autoclaved cages and were administered sulfamethoxazole and trimethoprim oral suspension (48 mg/ml in drinking water) for the first 3 wk postirradiation. All experiments were performed 8 wk after BM reconstitution. To verify the efficiency of reconstitution, BM was harvested from euthanized mice and differentiated into BM-derived macrophages (BMMs) as previously described (43) . BMMs were stimulated with LPS (0.1 g/ml) for 24 h and the presence or absence of IL-1␤ protein expression was determined by immunoblotting (data not shown).
Immunoblotting IL-1␤ protein expression and processing in skin homogenates and in BMMs was assayed by immunoblotting using polyclonal Abs against the cleaved and active form of IL-1␤ (Asp 116 ; rabbit anti-mouse 17-kDa cleaved IL-1␤ peptide; Cell Signaling Technology) and pro-IL-1␤ (goatanti-mouse IL-1␤; R&D Systems) as previously described (15, 44) .
Administration of recombinant murine IL-1␤
In some experiments (see Fig. 6 ), one dose of active recombinant murine IL-1␤ (rIL-1␤; 50 ng/100 l (R&D Systems)) in sterile pharmacy grade saline plus 0.1% endotoxin-free BSA (Sigma-Aldrich) as a carrier protein) or vehicle alone (saline plus 0.1% endotoxin-free BSA) was administered along with the s.c. inoculum of S. aureus (2 ϫ 10 6 CFUs/100 l) to IL-1␤-deficient mice. This s.c. dose of rIL-1␤ (50 ng/100 l) was previously shown in other models to be biologically active in vivo (45, 46) . Previous studies have also demonstrated that rIL-1␤ does not have any direct antimicrobial activity against S. aureus (47) (48) (49) .
Statistical analyses
Data were compared using a Student t test. All data are expressed as mean Ϯ SEM where indicated. Values of p Ͻ 0.05, p Ͻ 0.01, and p Ͻ 0.001 were considered statistically significant.
Results
IL-1␤-and IL-1␣/IL-1␤-, but not IL-1␣-, deficient mice develop markedly larger skin lesions with higher bacterial counts compared with wt mice after skin inoculation with S. aureus
Using a mouse model of a localized cutaneous infection with S. aureus, we previously reported that IL-1R-deficient mice developed larger lesions with higher bacterial counts compared with wt mice (15) . To investigate the differential contribution of the known activating ligands to IL-1R (i.e., IL-1␣ and IL-1␤) to the IL-1R-deficient mouse phenotype, we used the same S. aureus cutaneous infection model and inoculated wt mice and IL-1␣-, IL-1␤-, and IL-1␣/IL-1␤-deficient mice with a bioluminescent strain of S. aureus (SH1000 strain, 2 ϫ 10 6 CFUs/ 100 l) (15) . Lesion sizes and in vivo bioluminescence of live, actively metabolizing bacteria within the lesions over time were evaluated ( Fig. 1 ). wt mice developed visible skin lesions by day 3, which had a maximum size of 0.55 Ϯ 0.13 cm 2 , and healed by day 14 (Fig. 1, A and B) . IL-1␣-deficient mice developed skin lesions that did not significantly differ from lesion sizes of wt mice. In contrast, IL-1␤-and IL-1␣/IL-1␤-deficient mice developed Ͼ3-fold larger lesions than wt mice (or IL-1␣-deficient mice) that failed to completely heal by day 14 after the inoculation.
To determine whether the larger lesions of IL-1␤-and IL-1␣/IL-1␤-deficient mice were associated with a defect in bacterial clearance, we anesthetized mice and determined bacterial counts within the lesions over time using in vivo bioluminescence (Xenogen IVIS) ( Fig. 1, C and D) . We previously demonstrated that in vivo bioluminescence closely estimates bacterial CFUs harvested from the skin lesions at various time points after infection (15) . Following infection with S. aureus, wt and IL-1␣-deficient mice had similar bioluminescent signals that decreased over 14 days. In contrast, IL-1␤-and IL-1␣/IL-1␤deficient mice had increased bioluminescent signals (color scale) that were up to 10-fold higher (logarithmic scale) compared with wt mice at all time points following inoculation. Thus, IL-1␤and IL-1␣/IL-1␤-deficient mice have a defect in bacterial clearance, which likely explains the increased size and persistence of the skin lesions. Taken together, the phenotype of IL-1␤-deficient mice closely resembled that of IL-1␣/IL-1␤deficient mice, whereas the phenotype of IL-1␣-deficient mice did not significantly differ from that of wt mice. These data 
suggest that IL-1␤, and not IL-1␣, is the key IL-1R ligand involved in IL-1R-mediated host defense against a cutaneous S. aureus challenge. To confirm this result, in a separate experiment wt mice and IL-1␤and IL-1␣/IL-1␤-, along with IL-1Rdeficient mice were inoculated with S. aureus and lesion size and in vivo bioluminescence were measured as in Fig. 1 (data not shown). We found that IL-1␤-, IL-1␣/IL-1␤-, and IL-1Rdeficient mice all developed similarly increased lesion sizes and bioluminescent signals that were significantly greater than those of wt mice (data not shown), providing further evidence that IL-1␤ is the key mediator of IL-1R-dependent host defense against a S. aureus cutaneous challenge.
IL-1␤-, but not IL-1␣-, deficient mice have a defect in neutrophil recruitment compared with wt mice after skin inoculation with S. aureus
We previously reported that lesions of IL-1R-deficient mice have severely decreased neutrophil recruitment to the site of infection and decreased induction of neutrophil chemokines KC and MIP2 compared with wt mice. Because IL-1␤-deficient mice (but not IL-1␣-deficient mice) had a similar phenotype to IL-1R-deficient mice, namely increased lesion sizes and bioluminescent signals compared with wt mice, we evaluated the histology of lesional skin of wt, IL-1␣-, and IL-1␤-deficient mice at 1 day after inoculation with S. aureus ( Fig. 2A ). Lesions of wt and IL-1␣-deficient mice had large neutrophilic abscesses in both H&E and anti-Gr-1 (neutrophil marker) mAb-labeled histologic sections. In addition to Gr-1-positive neutrophils, there were scattered monocytes/macrophages throughout the abscesses that were detected with anti-Mac-3 (monocyte/macrophage marker) mAb (50) . These monocytes/macrophages were negative for F4/80 (data not shown), consistent with the monocyte/macrophage phenotype observed during skin inflammation (51, 52) . In addition, S. aureus bacteria were barely detectable by Gram stain in wt mice and IL-1␣-deficient mice, likely due to phagocytosis and clearance of the bacteria by the neutrophils within the abscess ( Fig. 2A) .
In contrast, lesions of IL-1␤-deficient mice had severely decreased numbers of neutrophils and Mac-3 ϩ monocytes/macrophages with no observable abscess formation and contained a blue-staining band of Gram-positive bacteria spanning the entire horizontal length of the section. Thus, IL-1␤-deficient mice but not IL-1␣-deficient mice have a severe defect in the recruitment of neutrophils to the site of infection with S. aureus. Furthermore, the readily detectable Gram-positive bacteria in lesions of IL-1␤-deficient mice corroborate the results obtained with in vivo bioluminescence, demonstrating that IL-1␤-deficient mice have impaired bacterial clearance. There was also significantly less MPO activity, a marker of phagocytic function, in homogenized lesional punch biopsy specimens of IL-1␤-deficient mice compared with wt mice at 1 day after inoculation with S. aureus (Fig. 2B ). In contrast, there was no difference in MPO activity in lesions of IL-1␣-deficient mice compared with wt mice. Taken together, these data demonstrate that IL-1␤-deficient mice have decreased neutrophil recruitment to the site of infection, suggesting that IL-1␤ is the predominant ligand that mediates IL-1R-dependent neutrophil recruitment to the site of infection.
IL-1␤-, but not IL-1␣-, deficient mice have impaired production of cytokines and chemokines involved in neutrophil recruitment in vivo after skin inoculation with S. aureus
The induction of cytokines and chemokines involved in neutrophil recruitment was evaluated in lesions of wt, IL-1␣-, and IL-1␤deficient mice. Protein levels of IL-1␤ and neutrophil chemokines KC and MIP2 were determined by performing ELISAs on homogenized 8-mm lesional punch biopsies performed at 0, 6, and 24 h after inoculation with S. aureus (Fig. 2C) . Lesions of IL-1␤-deficient mice had no detectable protein levels of IL-1␤ and significantly decreased protein levels of KC and MIP2 compared with lesions of wt mice at 6 h but not at 24 h after inoculation. In contrast, there was no difference in protein levels of IL-1␤, KC, and MIP2 between lesions of IL-1␣-deficient mice and wt mice. Thus, the decreased neutrophil recruitment in IL-1␤-deficient mice may in part be due to an early decreased production of cytokines and chemokines involved in neutrophil recruitment. In addition, we also evaluated protein levels of IL-1␣ by ELISA from homogenized lesional skin and found that wt and IL-1␤-deficient mice had constitutive expression of IL-1␣ at 0 h (which has been previously reported; Refs. 17, 20, 21) and was not further induced at 6 and 24 h after skin inoculation with S. aureus (Fig. 2D ). As expected, IL-1␣-deficient mice had virtually undetectable levels of IL-1␣ at all time points after infection. However, the presence or absence of IL-1␣ had little or no effect on IL-1R-dependent neutrophil recruitment since the phenotype of IL-1␣-deficient mice did not significantly differ from that of wt mice after S. aureus cutaneous challenge.
IL-1␤ protein is detected within the neutrophilic abscess after skin inoculation with S. aureus
The presence and distribution of IL-1␤ within the skin lesions was evaluated by immunoperoxidase labeling of IL-1␤ in frozen histologic sections of punch biopsies from lesional skin of wt, IL-1␣-, and IL-1␤-deficient mice performed at 1 day after s.c. inoculation with S. aureus (Fig. 3) . In histologic sections of lesions of wt and IL-1␣-deficient mice, IL-1␤ was expressed exclusively within the s.c. neutrophilic abscess, which contained cells expressing the neutrophil marker Gr-1. As an Ag control, we also performed immunoperoxidase labeling for IL-1␤ in histologic sections from lesions of IL-1␤-deficient mice and, as expected, no IL-1␤ was detected. These results demonstrate that IL-1␤ protein is expressed within the neutrophilic abscesses of lesional skin after inoculation with S. aureus. In contrast to histologic sections from S. aureus inoculated lesional skin, no neutrophilic infiltrate was seen and virtually no Gr-1 or IL-1␤ was expressed in histologic sections of skin biopsies performed at 1 day after a sham injection of vehicle/saline alone (data not shown).
Neutrophil recruitment in response to S. aureus infection is dependent upon IL-1␤ expression by BM-derived cells and not resident skin cells
Because the lesions of S. aureus-infected mice are comprised of both resident skin cells and recruited BM-derived cells, we wanted to determine which population of cells was important in promoting IL-1␤-dependent neutrophil recruitment and host defense. To address this question, we used a lethal dose of irradiation (1000 rad) to effectively eliminate all BM cells in the recipient mice. Lethally irradiated recipient wt mice were reconstituted with BM from donor wt or IL-1␤-deficient mice to generate two groups: 1) wt mice reconstituted with wt BM (wt BM3wt mice) and 2) wt mice reconstituted with IL-1␤-deficient BM (IL-1␤ Ϫ/Ϫ BM3wt mice). At 8 wk postreconstitution, these BM-reconstituted mice and normal nonirradiated/nonreconstituted wt and IL-1␤ Ϫ/Ϫ mice were s.c. inoculated with S. aureus as in Figs. 1 and 2 (Fig. 4, A-E) . IL-1␤ Ϫ/Ϫ BM3wt mice and IL-1␤ Ϫ/Ϫ mice developed 3-fold larger lesion sizes with at least 10-fold higher bioluminescent signals compared with wt BM3wt mice or wt control mice (Fig. 4,  A and B) . In addition, lesions of IL-1␤ Ϫ/Ϫ BM3wt mice and IL-1␤ Ϫ/Ϫ mice had markedly decreased neutrophilic abscess formation, abundant Gram-positive bacteria, and decreased MPO activity, and virtually undetectable levels of IL-1␤ protein compared with wt BM3wt mice or wt control mice ( Fig. 4, C-E) . These findings suggest that IL-1␤ expression by BM-derived cells is required for neutrophil recruitment and immunity against S. aureus.
To corroborate the requirement for BM-derived cells in promoting IL-1␤-dependent neutrophil recruitment and host defense, IL-1␤-deficient recipient mice were reconstituted with either wt or IL-1␤-deficient donor BM to generate two groups: 1) wt BM3 IL-1␤ Ϫ/Ϫ mice and 2) IL-1␤ Ϫ/Ϫ BM3 IL-1␤ Ϫ/Ϫ mice. At 8 wk postreconstitution, these BM-reconstituted mice and normal nonirradiated/nonreconstituted wt and IL-1␤ Ϫ/Ϫ mice were s.c. inoculated with S. aureus (Fig. 4, F-J) . wt BM3 IL-1␤ Ϫ/Ϫ mice had similar lesion sizes and bioluminescence signals as wt control mice, which were dramatically less than those of IL-1␤ Ϫ/Ϫ BM3 IL-1␤ Ϫ/Ϫ mice or IL-1␤ Ϫ/Ϫ mice (Fig. 4, F and G) . In addition, lesions of wt BM3 IL-1␤ Ϫ/Ϫ mice had similar neutrophilic abscess formation, MPO activity, and levels of IL-1␤ protein as wt mice, which were substantially greater than those of IL-1␤ Ϫ/Ϫ BM3 IL-1␤ Ϫ/Ϫ mice or IL-1␤ Ϫ/Ϫ mice (Fig. 4, H-J) . Taken together, these data demonstrate that IL-1␤ expression by BM-derived cells is required for adequate neutrophil recruitment and host defense against a cutaneous S. aureus challenge.
ASC-deficient mice developed larger lesions with increased bacterial counts and had defective neutrophil recruitment compared with wt mice after skin inoculation with S. aureus
A key event in the production of active IL-1␤ has been shown to be the proteolytic processing of pro-IL-1␤ by caspase-1. This processing is dependent upon the inflammasome, which facilitates caspase-1 activation and subsequent cleavage of pro-IL-1␤ into its active form (30 -33, 35) . Recently, in S. aureus-stimulated BMderived macrophage cultures, caspase-1 activation and subsequent generation of active IL-1␤ was found to be dependent upon the inflammasome component ASC (36) . Because we found that BMderived cells are required for production of IL-1␤ in response to a cutaneous S. aureus challenge, we hypothesized that ASC may be important in inflammasome-mediated production of active IL-1␤ during the infection in vivo. ASC-deficient, IL-1␤-deficient, and wt mice were s.c. inoculated with S. aureus as in Figs. 1 and 2 (Fig.  5) . ASC-and IL-1␤-deficient mice developed up to 3-fold larger lesions with increased bioluminescent signals (up to 12-fold higher) compared with wt mice (Fig. 5, A and B) . In addition, lesions of ASC-and IL-1␤-deficient mice had markedly decreased neutrophilic abscess formation, abundant Gram-positive bacteria, decreased MPO activity, and significantly decreased levels of KC and MIP2 compared with wt mice (Fig. 5, C-E) . Furthermore, we assessed the cleavage of pro-IL-1␤ into its active p17 form in tissue homogenates of lesional skin from wt and ASC-deficient mice at 1 day after inoculation with S. aureus. The active 17-kDa cleaved form of IL-1␤ (p17) was detected in lesional skin of wt but not ASC-deficient mice whereas pro-IL-1␤ was detected in lesions of both wt and ASC-deficient mice (Fig. 5F ), demonstrating that ASC is required for processing of IL-1␤ in vivo. Taken together, these findings demonstrate that ASC-deficient mice have a similar phenotype as IL-1␤-deficient mice and suggest that the inflammasome component ASC plays a key role in promoting the processing of IL-1␤ in vivo against a S. aureus cutaneous challenge.
Administration of active p17 rIL-1␤ with the S. aureus inoculum rescues IL-1␤-deficient mice
Given the critical role of IL-1␤ and ASC-mediated processing of IL-1␤ in promoting neutrophil recruitment and host defense against cutaneous S. aureus challenge, we evaluated whether the addition of active recombinant p17 IL-1␤ (rIL-1␤) could reduce the lesion sizes and bacterial counts observed in IL-1␤-deficient mice. Administration of one dose of rIL-1␤ (50 ng/100 l PBS) given with the S. aureus inoculum resulted in lesion sizes and bioluminescent signals that were significantly less than those of IL-1␤-deficient mice inoculated with S. aureus plus vehicle alone and closely resembled the lesion sizes and bioluminescent signals observed in wt mice (Fig. 6 ). Thus, administration of active rIL-1␤ rescued IL-1␤-deficient mice, demonstrating that the active form of IL-1␤ is required for IL-1R-dependent host defense and bacterial clearance against a cutaneous S. aureus challenge and further highlights the key role of ASC and the inflammasome in the generation of active IL-1␤ in vivo.
Discussion
Neutrophil recruitment is an essential innate immune response in host defense against S. aureus infections and is required for bacterial clearance (10, 11) . Using a model of S. aureus infection in the skin, we previously reported that activation of IL-1R-signaling by non-BM-derived resident skin cells is critical for neutrophil recruitment to the site of infection (15) . In the present study, we investigated the mechanism of IL-1R-mediated neutrophil recruitment against a cutaneous S. aureus challenge. We found that inflammasome-mediated production of active IL-1␤, and not IL-1␣, by BM-derived cells is required for IL-1R-dependent neutrophil recruitment in host defense against S. aureus in vivo.
Although both IL-1␣ and IL-1␤ use IL-1R to mediate their activity (17) (18) (19) (20) , there are key differences between these ligands, including the cellular source and posttranslational processing of these cytokines. IL-1␣ is constitutively expressed by epithelial cells (including keratinocytes) and endothelial cells (17) (18) (19) (20) 53) . In contrast, IL-1␤ production is induced by activated immune cells such as monocytes/macrophages, dendritic cells, and Langerhans cells (17) (18) (19) (20) . Despite the presence of detectable IL-1␣ in the skin before and during the infection (Fig. 2D ), our findings demonstrate that IL-1␤ induced after the infection, and not constitutively expressed IL-1␣, is the predominant mediator of IL-1R-dependent neutrophil recruitment in host defense against a S. aureus cutaneous challenge in vivo.
There is currently great interest in the mechanism of IL-1␤ processing in immune responses, with focus on the inflammasome as a key intracellular mediator for such processing (30 -33, 35) . IL-1␣ and IL-1␤ are products of different genes and are translated into distinct 31-kDa proteins (pro-IL-1␣ and pro-IL-1␤) (18, 20, 54, 55) . Pro-IL-1␣ is fully active in its precursor form and is believed to be released from intracellular stores upon cell death or lysis (18, 20, 21, 23) . After release, pro-IL-1␣ is cleaved into mature IL-1␣ by cell membrane-associated calpain proteases as well as extracellular proteases (18, 20, 56) . However, IL-1␣ did not play a major role in host defense or neutrophil recruitment against a S. aureus cutaneous challenge. In contrast to pro-IL-1␣, pro-IL-1␤ is an inactive precursor that requires cleavage by caspase-1 to generate 17-kDa active and secreted IL-1␤ (57, 58) . Caspase-1 activation is dependent upon activation of the inflammasome (29 -35) . Moreover, generation of active IL-1␤ by S. aureus-stimulated BM-derived macrophages in vitro was found to be dependent upon the inflammasome component ASC (36) . In the present study, ASC was also found to be required for the generation of active IL-1␤ in vivo and subsequent neutrophil recruitment and host defense against S. aureus (Fig. 5 ). This requirement for the inflammasome in generating active IL-1␤ in vivo was further supported by the ability of the administration of active rIL-1␤ to rescue the impaired host defense and bacterial clearance observed in IL-1␤deficient mice (Fig. 6 ). Thus, neutrophil recruitment in host defense against S. aureus cutaneous challenge requires inflammasome processing of IL-1␤ in vivo.
In the present study, we identified that BM-derived cells are required for production of IL-1␤ within the infected lesion, which subsequently activates IL-1R signaling. We previously described that the function of IL-1R-signaling on non-BM-derived resident cells is to promote neutrophil recruitment to the site of S. aureus infection in the skin (15) . Taken together, these data define a host defense circuit in which BM-derived cells are required for produc-tion of IL-1␤, which subsequently activates IL-1R expressed on non-BM-derived resident cells to promote neutrophil recruitment in host defense against a S. aureus cutaneous challenge. Our discovery that active IL-1␤ is required for IL-1R-dependent neutrophil recruitment in host defense against S. aureus in vivo is consistent with previous work demonstrating the importance of IL-1R activation in host defense against S. aureus brain abscesses, septic arthritis, and systemic infections (12) (13) (14) . Thus, the IL-1␤/IL-1R host defense circuit involving the interplay between BM-and non-BM-derived cells is likely a key innate immune mechanism for neutrophil recruitment against different types of S. aureus infections and perhaps other microbial pathogens. These other microbial pathogens may include Salmonella typhimurium and Francisella tularensis where the inflammasome has previously been shown to important in host defense and control of the infection (59 -61).
Matsukawa et al. (62) (63) (64) (65) previously demonstrated in acute inflammatory arthritis models in rabbits that IL-1␤ was responsible for optimal production of the neutrophil CXC chemokines, IL-8 and growth-related oncogene, which corresponded to maximal neutrophil recruitment. Mice, unlike humans and rabbits, do not have an ortholog to IL-8, but do produce KC and MIP2, which are related to growth-related oncogene chemokines (66 -68) . Similar to the previous studies using rabbit arthritis models, we found that IL-1␤ was also expressed within the neutrophilic abscess and played a major role in neutrophil recruitment and in the induction of chemokines (i.e., KC and MIP2) at the site of S. aureus infection in the skin of mice. Although the studies in rabbits used arthritis models and there are differences between the species, both sets of studies demonstrate that IL-1␤ plays a key role in neutrophil recruitment.
In another study by the same group, using a S. aureus-induced arthritis model in rabbits, blockade of IL-1␤ and/or TNF-␣ inhibited early but not later leukocyte infiltration or subsequent inflammation and joint damage/arthritis (69) . We previously demonstrated that TNF-␣ does not play a major role in host defense or in neutrophil recruitment to a site of S. aureus infection in the skin of mice (15) . In the present study and in previous studies, neutrophil recruitment to a site of S. aureus infection in the skin has been shown to be an event required for bacterial clearance (10, 11, 15) . Therefore, from a clinical point of view, augmentation of the IL-1␤/IL-1R host defense circuit may provide a potential basis for novel therapeutic strategies aimed at enhancing the host's own immune responses in the treatment of S. aureus infections in the skin.
